Nuveen Asset Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $5.84M | Sell |
151,197
-80,877
| -35% | -$3.12M | ﹤0.01% | 1908 |
|
2024
Q3 | $10.4M | Sell |
232,074
-141,918
| -38% | -$6.39M | ﹤0.01% | 1574 |
|
2024
Q2 | $13M | Sell |
373,992
-304,209
| -45% | -$10.5M | ﹤0.01% | 1418 |
|
2024
Q1 | $19.6M | Buy |
678,201
+372,782
| +122% | +$10.8M | 0.01% | 1194 |
|
2023
Q4 | $7M | Sell |
305,419
-230,605
| -43% | -$5.29M | ﹤0.01% | 1789 |
|
2023
Q3 | $8.94M | Sell |
536,024
-399,937
| -43% | -$6.67M | ﹤0.01% | 1544 |
|
2023
Q2 | $25.9M | Buy |
935,961
+107,490
| +13% | +$2.97M | 0.01% | 912 |
|
2023
Q1 | $19.1M | Buy |
828,471
+467,757
| +130% | +$10.8M | 0.01% | 1080 |
|
2022
Q4 | $3.94M | Buy |
360,714
+22,170
| +7% | +$242K | ﹤0.01% | 2052 |
|
2022
Q3 | $2.85M | Buy |
338,544
+572
| +0.2% | +$4.82K | ﹤0.01% | 2201 |
|
2022
Q2 | $2.67M | Buy |
337,972
+33,860
| +11% | +$268K | ﹤0.01% | 2290 |
|
2022
Q1 | $2.35M | Buy |
304,112
+64,183
| +27% | +$496K | ﹤0.01% | 2427 |
|
2021
Q4 | $1.85M | Buy |
239,929
+76,843
| +47% | +$594K | ﹤0.01% | 2599 |
|
2021
Q3 | $1.26M | Sell |
163,086
-3,239
| -2% | -$25K | ﹤0.01% | 2894 |
|
2021
Q2 | $1.29M | Buy |
166,325
+21,625
| +15% | +$167K | ﹤0.01% | 2911 |
|
2021
Q1 | $1.12M | Buy |
144,700
+32,129
| +29% | +$248K | ﹤0.01% | 2853 |
|
2020
Q4 | $870K | Sell |
112,571
-726
| -0.6% | -$5.61K | ﹤0.01% | 2853 |
|
2020
Q3 | $876K | Buy |
113,297
+22,525
| +25% | +$174K | ﹤0.01% | 2740 |
|
2020
Q2 | $701K | Sell |
90,772
-8,301
| -8% | -$64.1K | ﹤0.01% | 2773 |
|
2020
Q1 | $700K | Sell |
99,073
-95,364
| -49% | -$674K | ﹤0.01% | 2652 |
|
2019
Q4 | $1.37M | Buy |
194,437
+43,906
| +29% | +$309K | ﹤0.01% | 2578 |
|
2019
Q3 | $1.81M | Buy |
150,531
+111,656
| +287% | +$1.34M | ﹤0.01% | 2446 |
|
2019
Q2 | $470K | Buy |
+38,875
| New | +$470K | ﹤0.01% | 3015 |
|